Mural Oncology PLC
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Mural Oncology PLC
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Mural Oncology PLC stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Mural Oncology PLC by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Mural Oncology PLC is MURA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Mural Oncology PLC has its primary listing on NASDAQ. You can trade Mural Oncology PLC with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Mural Oncology PLC is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Mural Oncology PLC as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Mural Oncology PLC.